<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe the clinical spectrum, laboratory features, histopathological findings and treatment outcome in patients with <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">classical polyarteritis nodosa</z:e> (<z:chebi fb="59" ids="53571">PAN</z:chebi>) and <z:e sem="disease" ids="C0343192" disease_type="Disease or Syndrome" abbrv="">microscopic polyangiitis</z:e> (MPA) </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: Patients with <z:chebi fb="59" ids="53571">PAN</z:chebi> and MPA seen at a large teaching hospital in north India over a period of five years (1994-99) were included in the present study </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: We encountered five patients with <z:chebi fb="59" ids="53571">PAN</z:chebi> and six patients with MPA during the study period </plain></SENT>
<SENT sid="3" pm="."><plain>Of the five patients with <z:chebi fb="59" ids="53571">PAN</z:chebi>, two had <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> while three had limited <z:chebi fb="59" ids="53571">PAN</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The patients with limited <z:chebi fb="59" ids="53571">PAN</z:chebi> included two with cutaneous <z:chebi fb="59" ids="53571">PAN</z:chebi> and one with <z:chebi fb="59" ids="53571">PAN</z:chebi> confined to the nerves </plain></SENT>
<SENT sid="5" pm="."><plain>Constitutional symptoms, musculoskeletal complaints, <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> and <z:mp ids='MP_0001212'>skin lesions</z:mp> dominated the clinical picture </plain></SENT>
<SENT sid="6" pm="."><plain>Fifty percent of the MPA patients presented as <z:e sem="disease" ids="C0018085" disease_type="Disease or Syndrome" abbrv="">pulmonary renal syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients with <z:chebi fb="59" ids="53571">PAN</z:chebi> were HBsAg and <z:chebi fb="0" ids="34507">ANCA</z:chebi> negative and had <z:mpath ids='MPATH_458'>normal</z:mpath> urinalysis findings </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, <z:hpo ids='HP_0000001'>all</z:hpo> patients with MPA demonstrated an active urine sediment and 83.3% were pANCA positive </plain></SENT>
<SENT sid="9" pm="."><plain>Some of the rare features encountered by us were the presence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and extensive <z:hpo ids='HP_0006530'>interstitial lung disease</z:hpo> in MPA, and spontaneous recovery in one patient with systemic <z:chebi fb="59" ids="53571">PAN</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Treatment outcome was better in <z:chebi fb="59" ids="53571">PAN</z:chebi> as compared with MPA </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The clinical spectrum of <z:chebi fb="59" ids="53571">PAN</z:chebi> and MPA is quite varied </plain></SENT>
<SENT sid="12" pm="."><plain>A good outcome is possible with the use of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
</text></document>